ReviewNature reviews. Microbiology2026
Bifidobacteria: biogeography, host adaptation and ecological functions.
Review in Nature reviews. Microbiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Bifidobacteria are widely recognized important symbionts of the human gut microbiome, shaping host physiology from birth to adulthood to old age. Their evolutionary success is derived from metabolic versatility, ecological adaptation and intimate host interactions. Equipped with an expansive glycan-degrading repertoire, stress-response systems and specialized cell surface structures, bifidobacteria establish stable gut colonization and influence host immune, metabolic and neuroendocrine functions. Genomics and functional studies have revealed how human-associated members of this genus shape trophic networks, tolerance and resilience within the gut ecosystem. Integration of ecological, metabolic and immunological perspectives now positions the genus Bifidobacterium as an excellent model to support human gut health and its potential use as gut microbiota-based therapeutics.
Identifiers
42806067What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.